<html>
<head>PUBMED IDs for NKB1</head>
<body bgcolor='#C5F0F2'><h1>NKB1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/8145038/'>Polymorphic Hh genes in the HLA-B(C) region control natural killer cell frequency and activity.</a> April 1  1994<br><a href='https://pubmed.ncbi.nlm.nih.gov/8046332/'>NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules.</a> August 1  1994<br><a href='https://pubmed.ncbi.nlm.nih.gov/7897214/'>The NKB1 and HP-3E4 NK cells receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules.</a> April 1  1995<br><a href='https://pubmed.ncbi.nlm.nih.gov/9183630/'>Establishment and characterization of two human bladder cancer cell lines.</a> March 1  1996<br><a href='https://pubmed.ncbi.nlm.nih.gov/9501290/'>HLA-C and -Bw typing of couples with unexplained recurrent miscarriages.</a> March 21  1998<br><a href='https://pubmed.ncbi.nlm.nih.gov/9894849/'>Multiple transcripts of the killer cell immunoglobulin-like receptor family, KIR3DL1 (NKB1), are expressed by natural killer cells of a single individual.</a> January 23  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/11098931/'>Development of a PCR-SSOP approach capable of defining the natural killer cell inhibitory receptor (KIR) gene sequence repertoires.</a> December 1  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/12460192/'>Induction of 4-1BB (CD137) expression by DNA damaging agents in human T lymphocytes.</a> December 4  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12460147/'>A Japanese SPG4 family with a novel missense mutation of the SPG4 gene: intrafamilial variability in age at onset and clinical severity.</a> December 4  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/15466379/'>Clinicobiological, immunophenotypic, and molecular characteristics of monoclonal CD56-/+dim chronic natural killer cell large granular lymphocytosis.</a> October 7  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/23104321/'>Replacement treatment with microRNA-143 and -145 induces synergistic inhibition of the growth of human bladder cancer cells by regulating PI3K/Akt and MAPK signaling pathways.</a> January 31  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23392170/'>socs7, a target gene of microRNA-145, regulates interferon-Î² induction through STAT3 nuclear translocation in bladder cancer cells.</a> June 19  2013<br></body></html>
